INTRODUCTION
B lymphocytes mature into antibody-synthesizing and -secreting cells. They can be induced, in vitro, to change into antibody-producing cells by antigen together with a factor derived from sensitized T cells, lymphocyte mitogenic factor (LMF) .' Under such circumstances, agammaglobulinemia lack B lymphocytes from peripheral blood (4, 5) , lymph nodes, spleen, and bone marrow, sites where B lymphocytes are commonly found. Most patients with common, variable or "acquired" agammaglobulinemia have normal or increased numbers of circulating B lymphocytes (5, 6) . We previously reported (4) that 15 such patients either had B lymphocytes which were unresponsive to LMF and antigen (nine cases) or had B lymphocytes which responded normally by synthesizing gamma globulin but failed to secrete it (five cases) or had normal B cells when removed from a serum inhibitor present in the patient's blood (one case).
The present study concerns the B lymphocytes of four of the five patients whose cells had a secretory bloc. The fifth patient in this group was unavailable for study. It was of interest to study the glycosylation of newly synthesized gamma globulin in the B cells of the four patients with the secretory bloc. Glycosylation of gamma globulin normally occurs just before its secretion (7, 8) .
In the B lymphocytes of the four patients with the secretory bloc, it was found that no sugar was incorporated into newly synthesized gamma globulin.
METHODS
The four patients with aganmmaglobulinemia who donated their blood for the present study were identified in a previous report (4) as case numbers 13-3, 23-30, 23-13, and 18-12. The objectives of the study were explained to the patients or their parents, and informed consent was obtained.
B lymphocytes were obtained from the peripheral blood of the aforementioned agammaglobulinemic patients or normal donors, drawn into heparin, and subsequently admixed with 6%o dextran in saline (5: 1 volumes of heparinized blood: dextran). Leukocyte-rich plasma was decanted after 1 h at 370C and centrifuged for 10 min at 40C at 600 g. Pelleted leukocytes were suspended in Medium 199 containing 10%o autologous plasma; erythrocytes were lysed with 0.87%o chilled ammonium chloride, and the leukocytes were then washed twice in Hank's balanced salt solution before final suspension in Medium 199 containing 10%o AB+ serum. Leukocytes were passed through a column (50 X 3 cm) of prewarmed (370C) glass beads to eliminate polymorphonuclear leukocytes and monocytes. Viability of eluted cells was measured by trypan blue exclusion and found to exceed 90%o. B lymphocytes were separated from T lymphocytes on discontinuous gradients of bovine serum albumin and by E rosetting, as previously described (2) . 90-97% of cells in the final preparation formed rosettes with EAC3 and were considered to be B lymphocytes. On some occasions, the Erosetting step was omitted. This did not affect the results of IgG synthesis by the B cells.
LMF was prepared from cultures of T lymphocytes with tetanus toxoid as previously described (9) .
Purified B lymphocytes were suspended at a concentration of 2 X 106/ml in RPMI-1640 medium and mixed with an equal volume of LMF. After 6 days of culture at 370C in air containing 5%o CO2, the B cells were gently centrifuged and resuspended either in Medium 199 lacking leucine, valine, and isoleucine, or in Dulbecco medium containing 1 juM glucose at a leukocyte concentration of 2 X 106/ml. (Table I) .
The intracellular IgG from B lymphocytes of case 13-3 and extracellular fluid from a normal control was precipitated with specific antisera, and the precipitate was washed, dissolved in 1% sodium dodecyl sulfate, and reduced in 0.2 M dithiothreitol and subjected to electrophoresis in 5% polyacrylamide gel (12) . Two peaks of radioactivity were found which corresponded to the mobilities of normal H and L chains (Fig. 2) . When the experiment was done with labeled sugars instead of labeled amino acids the label was predominantly in the H chains of newly synthesized IgG. Small amounts of label in the L chain could not be excluded (less than 1%).
The possibility that these lymphocytes had a faulty intracellular transport mechanism for carbohydrate was considered. In an attempt to mimic the glycosylation defect of the agammaglobulinemic cells in normal B lymphocytes, cytochalasin B (10 ,sg/culture) was added to B cell cultures 4 h after the start of the incubation with labeled sugars. The exposure to cytochalasin was terminated 4 h later, and fresh labeled sugars were added for another 18 h of culture. Specific precipitates were then made of newly synthesized IgG with rabbit antihuman IgG and goat antirabbit IgG. The intracellular glycosylation of IgG was the same in control cultures (1,500 cpm/2 X 107 cells) as in the cytochalasin-treated cultures (1,750 cpm/2 X 10' cells), whereas cytochalasin effectively inhibited secretion of the IgG into the extracellular fluid (800 cpm/2 X 107 cells) compared with the control culture (9,000 cpm/2 X 107 cells).
B lymphocytes from case 13-3 were fixed in tannic acid-glutaraldehyde and examined under a Phillips-300 electron microscope (13 (16) or from the absence of a glycosylating enzyme in these cells. This also appears unlikely since the incorporation of labeled mannose and glucosamine into protein other than immunoglobulin proceeded in a normal fashion (Table I) .
The reason for the failure of glycosylation of immunoglobulin in the B cells of these agammaglobulinemic patients is not known but might be explained by an abnormality in the structure of the nascent heavy chain.
The site of attachment of the sugar residues to the protein chain is well known for some of the immunoglobulins. For instance, in the IgG1 molecules, the carbohydrate is attached to an asparagine molecule at residue 297 of the heavy chain (17) . In the present study, no abnormality of the heavy chains was discerned by gross examination of the newly synthesized IgG in polyacrylamide gels. Further studies will be required to define any subtle abnormality in the structure of the immunoglobulin produced by these abnormal B cells, if such abnormalities are indeed present.
